It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lipid peroxidation-induced ferroptosis is a newly recognized type of programmed cell death. With the method of RNA sequencing, we found that irradiation (IR) markedly increased the expression of ferroptosis promotive genes, whereas reduced the expression of ferroptosis suppressive genes in murine intestine tissues, when compared with those of liver and lung tissues. By using ferroptosis inducer RSL-3 and inhibitor liproxstatin-1, we found that ferroptosis is essential for IR-induced intestinal injury. Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) is an important component for ferroptosis execution, and we found that ACSL4 expression was significantly upregulated in irradiated intestine tissues, but not in liver or lung tissues. Antibacterial and antifungal regents reduced the expression of ASCL4 and protected against tissue injury in irradiated intestine tissues. Further studies showed that troglitazone, a ACSL4 inhibitor, succeeded to suppresses intestine lipid peroxidation and tissue damage after IR.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Jiangsu University, Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Zhenjiang, China (GRID:grid.440785.a) (ISNI:0000 0001 0743 511X)
2 Jiangsu University, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Zhenjiang, China (GRID:grid.440785.a) (ISNI:0000 0001 0743 511X)
3 Jiangsu University, Department of Burn and Plastic Surgery, Affiliated Hospital, Zhenjiang, China (GRID:grid.440785.a) (ISNI:0000 0001 0743 511X)
4 Jiangsu University, Department of Gastroenterology, Affiliated Hospital, Zhenjiang, China (GRID:grid.440785.a) (ISNI:0000 0001 0743 511X)
5 Jiangsu University, Department of Emergency Surgery, Affiliated Hospital, Zhenjiang, China (GRID:grid.440785.a) (ISNI:0000 0001 0743 511X)
6 The Affiliated People’s Hospital of Jiangsu University, Department of Neurology, Zhenjiang, China (GRID:grid.452247.2)